Paradromics has received FDA approval to study its brain-computer interface, designed to help people with paralysis communicate. The technology aims to send text or synthesized speech through the brain-computer interface, allowing users to express themselves. This development follows multiple breakthrough device designations and regulatory approvals, despite CEO Matt Angle criticizing competitors like Neuralink and Synchron.
Source: https://www.statnews.com/2025/11/20/fda-approves-paradromics-bci-trial-for-speech-restoration